235 related articles for article (PubMed ID: 17635828)
1. Concentrated heparin lock is associated with major bleeding complications after tunneled hemodialysis catheter placement.
Yevzlin AS; Sanchez RJ; Hiatt JG; Washington MH; Wakeen M; Hofmann RM; Becker YT
Semin Dial; 2007; 20(4):351-4. PubMed ID: 17635828
[TBL] [Abstract][Full Text] [Related]
2. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.
Power A; Duncan N; Singh SK; Brown W; Dalby E; Edwards C; Lynch K; Prout V; Cairns T; Griffith M; McLean A; Palmer A; Taube D
Am J Kidney Dis; 2009 Jun; 53(6):1034-41. PubMed ID: 19394731
[TBL] [Abstract][Full Text] [Related]
3. The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study.
Saxena AK; Panhotra BR
J Nephrol; 2005; 18(6):755-63. PubMed ID: 16358235
[TBL] [Abstract][Full Text] [Related]
4. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients.
Weijmer MC; van den Dorpel MA; Van de Ven PJ; ter Wee PM; van Geelen JA; Groeneveld JO; van Jaarsveld BC; Koopmans MG; le Poole CY; Schrander-Van der Meer AM; Siegert CE; Stas KJ;
J Am Soc Nephrol; 2005 Sep; 16(9):2769-77. PubMed ID: 16033861
[TBL] [Abstract][Full Text] [Related]
5. Effect of ultra-low dose and standard heparin locks on early tunnelled dialysis catheter outcomes in low-risk dialysis patients.
Renaud CJ; Lim EK; Tho SJ; Yeoh LY
Nephrology (Carlton); 2015 Feb; 20(2):85-90. PubMed ID: 25346031
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].
Barata JD; Oliveira C; Bruges M; Gusmão L; Santana A; Ponce P; Simões J; Freire I; Crespo F; da Silva AN
Acta Med Port; 1992 Feb; 5(2):65-70. PubMed ID: 1317657
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.
Moran J; Sun S; Khababa I; Pedan A; Doss S; Schiller B
Am J Kidney Dis; 2012 Jan; 59(1):102-7. PubMed ID: 22088576
[TBL] [Abstract][Full Text] [Related]
8. Locking solutions for hemodialysis catheters; heparin and citrate--a position paper by ASDIN.
Moran JE; Ash SR;
Semin Dial; 2008; 21(5):490-2. PubMed ID: 18764795
[TBL] [Abstract][Full Text] [Related]
9. Catheter lock heparin concentration: effects on tissue plasminogen activator use in tunneled cuffed catheters.
Holley JL; Bailey S
Hemodial Int; 2007 Jan; 11(1):96-8. PubMed ID: 17257362
[TBL] [Abstract][Full Text] [Related]
10. Impact of heparin locking frequency on preventing temporary dialysis catheter dysfunction in haemodialysis patients.
Oran NT; Eser I
J Ren Care; 2008 Dec; 34(4):199-202. PubMed ID: 19090898
[TBL] [Abstract][Full Text] [Related]
11. Successful prevention of cuffed hemodialysis catheter-related infection using an antibiotic lock technique by strictly catheter-restricted antibiotic lock solution method.
Zhang P; Yuan J; Tan H; Lv R; Chen J
Blood Purif; 2009; 27(2):206-11. PubMed ID: 19176949
[TBL] [Abstract][Full Text] [Related]
12. Locking tunneled hemodialysis catheters with hypertonic saline (26% NaCl) and heparin to prevent catheter-related bloodstream infections and thrombosis: a randomized, prospective trial.
Oguzhan N; Pala C; Sipahioglu MH; Cilan H; Durmaz S; Percin D; Unal A; Tokgoz B; Utas C; Oymak O
Ren Fail; 2012; 34(2):181-8. PubMed ID: 22260745
[TBL] [Abstract][Full Text] [Related]
13. Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: a randomised, double-blind clinical trial.
Saxena AK; Panhotra BR; Sundaram DS; Morsy MN; Al-Ghamdi AM
Nephrology (Carlton); 2006 Aug; 11(4):299-305. PubMed ID: 16889569
[TBL] [Abstract][Full Text] [Related]
14. Low-dose heparin retention in temporary hemodialysis double-lumen catheter does not increase catheter occlusion and might reduce risk of bleeding.
Hu HH; Hsu CY; Fang HC; Lee PT; Chen CL; Chang TY; Huang WC; Chung HM; Chou KJ
Blood Purif; 2011; 32(3):232-7. PubMed ID: 21829015
[TBL] [Abstract][Full Text] [Related]
15. Inadvertent postdialysis anticoagulation due to heparin line locks.
Pepper RJ; Gale DP; Wajed J; Bommayya G; Ashby D; McLean A; Laffan M; Maxwell PH
Hemodial Int; 2007 Oct; 11(4):430-4. PubMed ID: 17922740
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection.
Jaffer Y; Selby NM; Taal MW; Fluck RJ; McIntyre CW
Am J Kidney Dis; 2008 Feb; 51(2):233-41. PubMed ID: 18215701
[TBL] [Abstract][Full Text] [Related]
17. A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: the HIP (Heparin Infusion for PCVC) study.
Shah PS; Kalyn A; Satodia P; Dunn MS; Parvez B; Daneman A; Salem S; Glanc P; Ohlsson A; Shah V
Pediatrics; 2007 Jan; 119(1):e284-91. PubMed ID: 17200252
[TBL] [Abstract][Full Text] [Related]
18. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters.
Yon CK; Low CL
Am J Health Syst Pharm; 2013 Jan; 70(2):131-6. PubMed ID: 23292266
[TBL] [Abstract][Full Text] [Related]
19. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.
Betjes MG; van Agteren M
Nephrol Dial Transplant; 2004 Jun; 19(6):1546-51. PubMed ID: 14993498
[TBL] [Abstract][Full Text] [Related]
20. Measuring of the heparin leakage into the circulation from central venous catheters--an in vivo study.
Markota I; Markota D; Tomic M
Nephrol Dial Transplant; 2009 May; 24(5):1550-3. PubMed ID: 19075195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
